Highly Active Antiretroviral Therapy Versus Zidovudine for Prevention of Mother-to-Child Transmission in a Programmatic Setting, Botswana

被引:13
|
作者
Dryden-Peterson, Scott [1 ,2 ,3 ]
Jayeoba, Oluwemimo [2 ]
Hughes, Michael D. [4 ]
Jibril, Haruna [5 ]
Keapoletswe, Koona [5 ]
Tlale, Josephine [5 ]
Modise, Taolo A. [2 ]
Asmelash, Aida [2 ]
Moyo, Sikhulile [2 ]
van Widenfelt, Erik [2 ]
Makhema, Joseph [2 ]
Essex, Max [2 ,3 ]
Shapiro, Roger L. [2 ,3 ]
Lockman, Shahin [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Div Infect Dis, Dept Med, Boston, MA 02115 USA
[2] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[3] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[5] Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; PREGNANCY; REGIMENS; DISEASE; TRIAL; WOMEN; LOAD;
D O I
10.1097/QAI.0b013e31822d4063
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Few studies have compared the programmatic effectiveness of the recommended strategies of antenatal highly active antiretroviral therapy (HAART) and zidovudine for prevention of mother-to-child transmission. We prospectively followed infants (93% formula fed) whose mothers who took either HAART (258 infants) or zidovudine (170 infants) during pregnancy in the Botswana national program. Overall, 10 infants (2.5%) acquired HIV-9 infants in the zidovudine group (5.5%, 95% confidence interval: 2.6% to 10.2%) and 1 infant in the HAART group (0.4%, 95% confidence interval: 0.0% to 2.2%). Maternal HAART was associated with decreased prevention of mother-to-child transmission (P = 0.001) and improved HIV-free survival (P = 0.040) compared with zidovudine (with or without single-dose nevirapine) in a programmatic setting.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 50 条
  • [1] The value of highly active antiretroviral therapy in the prevention of mother-to-child transmission of HIV
    Chama, C.
    Gashau, W.
    Oguche, S.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (02) : 134 - 137
  • [2] Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy
    Giaquinto, C
    Ruga, E
    De Rossi, A
    Grosch-Wörner, I
    Mok, J
    de José, I
    Bates, I
    Hawkins, F
    de Guevara, CL
    Peña, JM
    Garcia, JG
    Lopez, JRA
    Garcia-Rodriguez, MC
    Asensi-Botet, F
    Otero, MC
    Pérez-Tamarit, DP
    Suarez, G
    Scherpbier, H
    Kreyenbroek, M
    Boer, K
    Bohlin, AB
    Lindgren, S
    Ehrnst, A
    Belfrage, E
    Navér, L
    Lidman, K
    Anzen, B
    Levy, J
    Barlow, P
    Hainaut, M
    Peltier, A
    Goetghebuer, T
    Ferrazin, A
    Bassetti, D
    De Maria, A
    Gotta, C
    Mûr, A
    Payà, A
    Viñolas, M
    López-Vilchez, MA
    Rovira
    Carreras, R
    Valerius, NH
    Jimenez, J
    Coll, O
    Suy, A
    Perez, JM
    Fortuny, C
    Caro, MC
    Canet, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (03) : 458 - 465
  • [3] Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy
    Medrano, Jose
    Soriano, Vicente
    [J]. MEDICINA CLINICA, 2009, 132 (13): : 505 - 506
  • [4] The use of highly active antiretroviral therapy for the prevention of mother-to-child transmission of the human immunodeficiency virus in Nigeria
    Chama, C. M.
    Bello, M.
    Ajayi, B. A.
    Zarma, S.
    Gashau, W.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 30 (04) : 362 - 366
  • [5] Prevention of Mother-to-Child Transmission of HIV-1 Using Highly Active Antiretroviral Therapy in Rural Yunnan, China
    Zhou, Zengquan
    Meyers, Kathrine
    Li, Xia
    Chen, Qingling
    Qian, Haoyu
    Lao, Yunfei
    Geng, Elvin
    Fan, Yishan
    Yang, Shaomin
    Chiu, Michael
    Ho, David D.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 53 : S15 - S22
  • [6] Prevention of Mother-to-Child Transmission of HIV: Antiretroviral Strategies
    Read, Jennifer S.
    [J]. CLINICS IN PERINATOLOGY, 2010, 37 (04) : 765 - +
  • [7] Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
    Ngemu E.K.
    Khayeka-Wandabwa C.
    Kweka E.J.
    Choge J.K.
    Anino E.
    Oyoo-Okoth E.
    [J]. BMC Research Notes, 7 (1)
  • [8] Antiretroviral therapy in Prevention of Mother-to-child Transmission of HIV in Odessa region, Ukraine
    Posokhova, S
    Penin, O
    Nizova, N
    Sidyachenko, A
    [J]. XIV INTERNATIONAL AIDS CONFERENCE: INTERVENTIONS AND PROGRAM IMPLEMENTATION, 2002, : 433 - 436
  • [9] Mother-to-child transmission of HIV in Botswana
    Bagcchi, Sanjeet
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (03): : 319 - 319
  • [10] Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?
    Briand, Nelly
    Warszawski, Josiane
    Mandelbrot, Laurent
    Dollfus, Catherine
    Pannier, Emmanuelle
    Cravello, Ludovic
    Rose Nguyen
    Matheron, Isabelle
    Winer, Norbert
    Tubiana, Roland
    Rouzioux, Christine
    Faye, Albert
    Blanche, Stephane
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (06) : 903 - 914